Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

How Do Dual Long-acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?

Research output: Contribution to journalJournal articleResearchpeer-review

  1. High Prevalence of Laryngeal Obstruction during Exercise in Severe Asthma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. CDHR3 Genetics and Rhinovirus C Respiratory Illnesses

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Exposure Interaction - A Life-long Phenomenon with Relevance to Chronic Obstructive Pulmonary Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Fletcher and Peto 40 Years on. A tribute and reflection

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Laryngeal Dysfunction - Assessment and Management for the Clinician

    Research output: Contribution to journalReviewResearchpeer-review

  1. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

    Research output: Contribution to journalReviewResearchpeer-review

  2. COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Female asthma and atopy - impact on fertility: a systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Kai M Beeh
  • Pierre-Regis Burgel
  • Frits M E Franssen
  • Jose Luis Lopez-Campos
  • Stelios Loukides
  • John R Hurst
  • Matjaž Fležar
  • Charlotte Suppli Ulrik
  • Fabiano Di Marco
  • Daiana Stolz
  • Arschang Valipour
  • Brian Casserly
  • Björn Ställberg
  • Konstantinos Kostikas
  • Jadwiga A Wedzicha
View graph of relations

Decreasing the frequency and severity of exacerbations is one of the main goals of treatment for patients with chronic obstructive pulmonary disease (COPD). Several studies have documented that long-acting bronchodilators (LABDs) can reduce exacerbation rate and/or severity, and others have shown that combinations of long-acting 2-adrenergic agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) provide greater reductions in exacerbation frequency than either their monocomponents or LABA/inhaled corticosteroids (LABA/ICS) combinations in patients at low and high risk for these events. In this review, small groups of experts critically evaluated mechanisms potentially responsible for the increased benefit of LABA/LAMA combinations over single LABDs or LABA/ICS in decreasing exacerbation. These included effects on lung hyperinflation and mechanical stress, inflammation, excessive mucus production with impaired mucociliary clearance, and symptom severity. The data assembled and analyzed by each group were reviewed by all authors and combined into this manuscript. Available clinical results support the possibility that effects of LABA/LAMA combinations on hyperinflation, mucociliary clearance, and symptom severity may all contribute to decreasing exacerbations. While preclinical studies suggest LABAs and LAMAs have anti-inflammatory effects, such effects have not been demonstrated yet in patients with COPD.

Original languageEnglish
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume196
Issue number2
Pages (from-to)139-149
ISSN1073-449X
DOIs
Publication statusPublished - Jul 2017

ID: 49302575